Virginia Commonwealth University’s Stravitz-Sanyal Institute for Liver Disease and Metabolic Health has announced a partnership with Singapore -headquartered medtech company, Histoindex Pte Ltd.
Can-Fite BioPharma Ltd today announced that it received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) with respect to the submission of a registration plan for a pivotal Phase III clinical trial for the treatment of moderate to severe psoriasis.
Exact Sciences Corp., a leading provider of cancer screening and diagnostic tests, announced that the company plans to release its first quarter 2023 financial results after the close of the U.S. financial markets on May 9, 2023.
Exact Sciences schedules first quarter 2023 earnings call Read More »
Theravance Biopharma, Inc. will present at the 22nd Annual Needham Virtual Healthcare Conference on Monday, April 17 at 3:45 pm ET.
Theravance Biopharma to Participate in an Upcoming April 2023 Investor Conference Read More »
Mainz Biomed N.V. announced financial results for the fiscal year ended December 31, 2022.
Mainz Biomed Provides Full Year 2022 Financial Results Read More »
OBI Pharma, Inc. announced preclinical data demonstrating significant synergistic effects of OBI-999 and pembrolizumab in four different cancer models, as well as the potent antitumor effect of a chimeric antigen receptor T-cell immunotherapy targeting Globo H.
Verona Pharma plc announces its development partner, Nuance Pharma, has dosed the first subject in its ENHANCE – China Phase 3 trial for the maintenance treatment of chronic obstructive pulmonary disease.
GC Genome Corporation announced the publication of a new study in Radiation Oncology Journal, which demonstrates the feasibility of cell-free DNA monitoring to predict treatment response and detect minimal residual disease after radiation therapy in solid tumor patients using I-score, a tool for calculating genomic instabilities developed by GC Genome.
Syncell, a biotech company pioneering in platforms for hypothesis-free spatial proteomics, will be exhibiting and presenting a poster at the AACR Annual Meeting 2023 in Orlando, FL. Syncell’s Microscoop technology enables microscopy-guided subcellular protein scooping in ultra-content powered by AI to collect enough proteins for subsequent spatial proteomic identification.
2HCmed Innovations Co., Ltd., a contract development and manufacturing organization, announced the appointment of Gunilla Petersson, Ph.D. as the new Chief Scientific Officer.
